Marked increase of procalcitonin after the administration of anti-thymocyte globulin in patients before hematopoietic stem cell transplantation does not indicate sepsis: a prospective study
-
* Corresponding author: Marketa Markova marketa.markova@uhkt.cz
Critical Care 2009, 13:R37 doi:10.1186/cc7749
See related commentary by McLean, http://ccforum.com/content/13/3/149
No comments have yet been made on this article.